SeerPharma Blog

Data Integrity - Intentional, Unintentional and Potential

September 14, 2021

Data Integrity (DI) has become a common issue and a key area of focus for regulators in our industry. Trust is at the cornerstone of relations between industry, regulatory bodies, the health sector, and patients(consumer). Data is evidence of the activity that has been performed. Regulatory bodies entirely rely on the accuracy and completeness...

Read More

SeerPharma Launches Suite of GMP Training Programs for India

August 17, 2021

For over 30 years, SeerPharma has been at the forefront assisting pharmaceutical and medical device manufacturers on matters related to Quality and GMP compliance in the Asia-Pacific region. Over this period, we have seen a growing interest and engagement in our service and offerings from pharmaceutical manufacturers located in India. This...

Read More

SeerPharma to Sponsor BioSymposium on Precision Medicine

August 10, 2021

SeerPharma is excited to be sponsoring BioMelbourne Network’s BioSymposium on Advancements in Precision Medicine – Opportunities, Challenges and Economics. The event to be held Friday the 3rd of September 2021.

Read More

SeerPharma Welcomes Spring 2021 Postgraduate GMP Students at UTS

August 03, 2021

SeerPharma is thrilled to welcome the 2021 Spring cohort of students studying Good Manufacturing Practice (GMP) at the University of Technology Sydney. This cohort is a global blend of graduates and industry professionals. Our investments with migrating this program online over several years has placed us in a strong position through the...

Read More

Free Information Session on Upcoming Subsidised QMS Training

July 22, 2021

Research and operations of Medical Technology, Biotechnology and Pharmaceutical (MTP) companies aligned with and in some cases certified to Quality Management System (QMS) Standards will ensure Australia is at the forefront of medical innovation.

Read More

Validation 4.0 – A Near Future State

July 15, 2021

ISPE recently hosted a webinar on Validation 4.0 and where it sat within their ISPE Pharma 4.0TM Operation Model. It was with no surprise that an audience survey rated ‘documentation’ as the biggest hurdle / constraint to validation.

Read More

Assisting an Analytical Testing Laboratory with US FDA Inspection

June 21, 2021

Chemika is an independently owned chemical analysis laboratory located in  Girraween, Sydney, and is licensed with the Therapeutic Goods Administration (TGA) and the Australian Pesticides and Veterinary Medicines Association (APVMA). Chemika provide chemical testing services to manufacturers of human therapeutics and veterinary medicine....

Read More

Meet Mario Cano Gorra - Master of GMP Student at UTS

June 14, 2021

I am a Mexican-born citizen. Since elementary school, I’ve displayed a natural knack for biology, physics, and mathematics. Naturally, I studied a Bachelor of Science in Pharmaceutical Engineering in one of the largest and most prestigious universities in Mexico, the National Polytechnic Institute. Whilst studying I met my wife, and we have...

Read More

Monitoring the Pulse of Precision Medicine: 2021 Trends in Personalised Medicine

June 09, 2021

Let’s just say what we’re all thinking: 2020 was rough. It threw pretty much every element of our lives into disarray, and we suddenly had to become experts at navigating a new way of working, schooling and socialising. It was disruptive, and it was challenging, but it was also transformative. While the past 12 months might have felt like 12...

Read More

Medical Devices: Post-Market Surveillance, Adverse Events and Recall

June 01, 2021


Read More